Vendor Question and Answer.docx
DOCX document 12 KB Posted
- Attached to
- Virology Molecular Testing
- Solicitation number
- W91YTZ20R0013
- Issued by
-
Department of the Army Medical Command
About this file
This document contains vendor questions and answers related to solicitation number W91YTZ20R0013 for virology molecular testing services. The questions and answers provide guidance on submitting pricing data using the specified table format from FAR 15.408, attaching the required Medical Device Cybersecurity Assessment Questionnaire and Risk Management Framework forms, and clarifying the estimated annual testing volumes of HCV, Zika, and HIV. Specifically, HCV testing volume is estimated at 50-100 annually, Zika at 400-500 annually, and HIV at 0-10 annually. Offerors are to use the test and volume information in Section 2.6 of the statement of work to develop their pricing.
View the file
Other files
| File | Type | Posted |
|---|---|---|
| DDEAMC RMF New System Questionnaire.pdf | ||
| W91YTZ20R0013-COMBINED SYNOPSIS SOLICITATION.docx | DOCX document |
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Vendor Questions
1. Requirements for Cost or Pricing Data, Sec. b(i), p. 9: Is Table 15-2 of FAR 15.408 the only acceptable format for submitting pricing data or may Abbott submit pricing data in an alternative format? (Please see attached “Table 15-2” from the solicitation) Answer: Use table specified in solicitation.
2. Cyber-Security Requirements, Sec B-1.1, p. 75: Where can Contractor’s find the Medical Device Cybersecurity Assessment Questionnaire?
Answer: Form attached.
3. Offeror’s pricing is based on volumes, can you confirm that we can use the Table in Section 2.6 -Statement of Work as our basis for pricing (list of tests and volumes)?
Answer: Yes. The table offered in the SOW is correct and can be used to provide quotes and prices /plus each contract line item.
4. With respect to the section detailing RMF requirements, we have previously completed an Medical Device Risk Assessment (MDRA) questionnaire for another DOD facility as well as an MDS2 (Manufacturer Disclosure Statement for Medical Device Security). Would either of these forms be sufficient to submit with our package? If not, can you please direct me to the specific form you require?
Answer: Form attached
5. In the Annual Estimated Volumes table in Section 2.6 of the Statement of Work, HIV, HCV, and Zika have a combined total of 500. Is the estimated volume 500 each or can you provide a volume breakdown of each assay?
Answer: HCV = 50-100/annually; Zika = 400-500/annually; HIV = 0-10/annually.
NOTE: These numbers are given from historical data. They are subject to change due to DoD policy, patient workload volatility and other factors outside of our control.
File details come from the government source that posted it. Updated .